within Pharmacolibrary.Drugs.R_RespiratorySystem.R03A_AdrenergicsInhalants.R03AC09_Tretoquinol;

model Tretoquinol
  extends Pharmacolibrary.Drugs.ATC.R.R03AC09;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>R03AC09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tretoquinol is a selective beta-2 adrenergic agonist that has bronchodilator effects. It has been used mainly in Japan for the treatment of asthma and other respiratory conditions. The drug is not widely used or approved in most countries today.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic data found for tretoquinol in humans. The following parameter values are estimated based on typical beta-2 agonist pharmacokinetics such as salbutamol.</p><h4>References</h4><ol><li><p>Sugihara, J, et al., &amp; Harigaya, S (1988). Studies on intestinal lymphatic absorption of drugs. I. Lymphatic absorption of alkyl ester derivatives and alpha-monoglyceride derivatives of drugs. <i>Journal of pharmacobio-dynamics</i> 11(5) 369–376. DOI:<a href=\"https://doi.org/10.1248/bpb1978.11.369\">10.1248/bpb1978.11.369</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/3171878/\">https://pubmed.ncbi.nlm.nih.gov/3171878</a></p></li><li><p>Camargo, FC, et al., &amp; Tobin, T (2006). Intravenous and intratracheal administration of trimetoquinol, a fast-acting short-lived bronchodilator in horses with &#x27;heaves&#x27;. <i>Equine veterinary journal</i> 38(6) 563–569. DOI:<a href=\"https://doi.org/10.2746/042516406x153355\">10.2746/042516406x153355</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17124848/\">https://pubmed.ncbi.nlm.nih.gov/17124848</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Tretoquinol;
